Blind World


Retinitis Pigmentosa: New Treatment Study for RP Actively Recruiting Patients.





March 24, 2004.

Clinical Coordinator,
The Massachusetts Eye and Ear Infirmary.
Phone: 617) 573-3602.




A new treatment study for retinitis pigmentosa (RP) is being conducted under the supervision of Dr. Eliot Berson at the Massachusetts Eye and Ear Infirmary in Boston with the support of the National Eye Institute and the assistance of The Foundation Fighting Blindness.


Eligible patients must:

Have retinitis pigmentosa (RP);
Be between the ages of 18 and 60;
Reside in the United States;
Be able to see the whole face of someone sitting across the table without scanning;
Read newspaper-size print without special magnifying aids;
and Walk unaided in daylight.


Women who are pregnant or planning to become pregnant are not eligible.


All participants will take a daily supplement of 15,000 IU of vitamin A in addition to the medication under study.


Eye examinations, the tablets under study, and the vitamin A will be provided at no cost to the patients at the Massachusetts Eye and Ear Infirmary in Boston.


Potentially eligible individuals are encouraged to participate.


If you are interested in participating, please call the Massachusetts Eye and Ear Infirmary at (617) 573-3602 and ask for the clinical coordinator.


You will be asked questions to help determine whether you meet the pre-set list of eligibility requirements.




End of article.






Go to ...


Top of Page.

Previous Page.

List of Categories.

Home Page.





Blind World Website
Designed and Maintained by:
George Cassell
All Rights Reserved.



Copyright Notice
and Disclaimer.